Pediatric Cancer Clinical Trials in Houston, Texas

5 studies are recruiting for pediatric cancer in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 25

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT06458036 on ClinicalTrials.gov

2. Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

   It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) …

   Stage

   Not phased

   Ages

   Any age

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   3 in total

   Run by

   Nemours Children's Clinic

   See if you can join NCT05294302 on ClinicalTrials.gov

3. Targeted Therapy to Increase RAI Uptake in Metastatic DTC

   Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…

   Stage

   Not phased

   Ages

   0 and older

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   9 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05024929 on ClinicalTrials.gov

4. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 99

   Site

   MD Anderson Cancer Center, Houston, Texas

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05783323 on ClinicalTrials.gov

5. Childhood Cancer Predisposition Study (CCPS)

   The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h…

   Stage

   Not phased

   Ages

   Any age

   Site

   Baylor College of Medicine, Houston, Texas

   Locations

   7 in total

   Run by

   Emory University

   See if you can join NCT04511806 on ClinicalTrials.gov